SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that COVID-19 RT-PCR testing volume has increased in 2022 ...
For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or from human DNA. But PCR, ...
Early in the pandemic, when someone walked into a clinic with a possible case of COVID-19, a nurse or doctor would stick a long swab up their nose to take a sample. They would then ship it to a ...
The RT-PCR test amplifies the virus’ genetic material (RNA) from throat swabs of the patients, converts it to DNA, amplifies it and checks it for designated markers to see whether it is the Sars-Cov-2 ...
At-home COVID-19 tests have become an easy way to self-diagnose. But current tests have drawbacks, such as the length of time it takes to get an answer, or how accurately the test can identify a ...
In a recent study posted to the Lancet preprint* server, researchers assessed the utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapid antigen testing (RAT) for patient triage ...
About The Study: Researchers compared the accuracy of rapid antigen tests with reverse transcriptase–polymerase chain reaction (RT-PCR) tests in detecting SARS-CoV-2 infection among 723 college ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback